EP3416977A4 - Treatment of traumatic brain injury or stroke - Google Patents

Treatment of traumatic brain injury or stroke Download PDF

Info

Publication number
EP3416977A4
EP3416977A4 EP17753766.9A EP17753766A EP3416977A4 EP 3416977 A4 EP3416977 A4 EP 3416977A4 EP 17753766 A EP17753766 A EP 17753766A EP 3416977 A4 EP3416977 A4 EP 3416977A4
Authority
EP
European Patent Office
Prior art keywords
stroke
treatment
brain injury
traumatic brain
traumatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17753766.9A
Other languages
German (de)
French (fr)
Other versions
EP3416977A1 (en
Inventor
Torsten FALK
Robin Polt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizona Board of Regents of University of Arizona
University of Arizona
Original Assignee
Arizona Board of Regents of University of Arizona
University of Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/044,924 external-priority patent/US10117907B2/en
Application filed by Arizona Board of Regents of University of Arizona, University of Arizona filed Critical Arizona Board of Regents of University of Arizona
Publication of EP3416977A1 publication Critical patent/EP3416977A1/en
Publication of EP3416977A4 publication Critical patent/EP3416977A4/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
EP17753766.9A 2016-02-16 2017-02-15 Treatment of traumatic brain injury or stroke Pending EP3416977A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/044,924 US10117907B2 (en) 2013-08-14 2016-02-16 Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases
PCT/US2017/017995 WO2017142961A1 (en) 2016-02-16 2017-02-15 Treatment of traumatic brain injury or stroke

Publications (2)

Publication Number Publication Date
EP3416977A1 EP3416977A1 (en) 2018-12-26
EP3416977A4 true EP3416977A4 (en) 2019-07-17

Family

ID=59626395

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17753766.9A Pending EP3416977A4 (en) 2016-02-16 2017-02-15 Treatment of traumatic brain injury or stroke

Country Status (2)

Country Link
EP (1) EP3416977A4 (en)
WO (1) WO2017142961A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR113022A1 (en) 2017-09-29 2020-01-15 Lilly Co Eli ANTI-PACAP ANTIBODY

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017027848A1 (en) * 2015-08-12 2017-02-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010313122A1 (en) * 2009-11-02 2012-05-24 The Administrators Of The Tulane Educational Fund Analogs of pitutary adenylate cyclase-activating polypeptide (PACAP) and methods for their use
EP3035950A4 (en) * 2013-08-14 2017-05-03 The Arizona Board Of Regents On Behalf Of The University Of Arizona Glycosylated pacap/vip analogues with enhanced cns penetration for treatment of neurodegenerative diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017027848A1 (en) * 2015-08-12 2017-02-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HELLEWELL SARAH ET AL: "Therapies negating neuroinflammation after brain trauma", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 1640, 29 December 2015 (2015-12-29), pages 36 - 56, XP029537389, ISSN: 0006-8993, DOI: 10.1016/J.BRAINRES.2015.12.024 *
MOHAMMAD NASSER ET AL: "CNS & Neurological Disorders -Drug Targets Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk", CNS & NEUROLOGICAL DISORDERS -DRUG TARGETS, 1 January 2016 (2016-01-01), pages 1030 - 1044, XP055595039, Retrieved from the Internet <URL:http://www.eurekaselect.com/144807/article> [retrieved on 20190607], DOI: 10.2174/18715273156661608150935 *
See also references of WO2017142961A1 *

Also Published As

Publication number Publication date
EP3416977A1 (en) 2018-12-26
WO2017142961A1 (en) 2017-08-24

Similar Documents

Publication Publication Date Title
EP3568129A4 (en) Glyceryl 3-hydroxybutyrates for traumatic brain injury
EP3331525A4 (en) Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
EP3302249A4 (en) Diagnosis of mild traumatic brain injury
EP3712280B8 (en) Biomarkers of traumatic brain injury
EP3426250A4 (en) Methods of treatment
EP3197482A4 (en) Methods of treating traumatic brain injury
HK1249865B (en) Treatment of pain
EP3472623A4 (en) Exosome-guided treatment of cancer
EP3413827A4 (en) Devices for image-guided light treatment of skin
EP3630065A4 (en) Treatment of depressive disorders
EP3182992A4 (en) Methods of treating mild brain injury
HK1247884A1 (en) Method for cosmetic treatment of the skin
EP3458062A4 (en) Treatment of pain
EP3484477A4 (en) Treatment of cancer
GB201607388D0 (en) Treatment of impulsivity-related disorders
IL268187A (en) Use of senicapoc for treatment of stroke
ZA201807692B (en) New use of product for skin treatment
EP3532045A4 (en) Use of senicapoc for treatment of neuropathic pain
PL3448340T3 (en) Application aid for the treatment of wounds
EP3271017A4 (en) Treatment of skin conditions
EP3362067A4 (en) Methods and compositions for treating traumatic brain injury
EP3416977A4 (en) Treatment of traumatic brain injury or stroke
IL275027A (en) Treatment of rsv with combination product
EP3703730A4 (en) Methods for treating traumatic brain injury
EP3727376A4 (en) Methods of treatment of hypertrigl yceridemia

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180917

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190619

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 39/00 20060101ALI20190613BHEP

Ipc: C07K 14/00 20060101AFI20190613BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210218

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS